NCT02164461 2024-05-20
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Advaxis, Inc.
Phase 1 Completed
Clinical Trials
22 trialsNCT02728830 2024-02-21
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Duke University
Phase EARLY_PHASE1 Completed
NCT04679675 2023-09-18
STEP
Kaiser Permanente
Phase NA Completed
NCT02609880 2023-06-15
Cognitive Behavioral Effects on Sleep, Pain, and Cytokines in Gynecologic Cancer
University of Florida
Phase NA Completed
NCT03562897 2022-07-06
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer
Catalysis SL
Phase 2 Completed
NCT02978755 2022-04-06
First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers
GamaMabs Pharma
Phase 1 Completed
NCT01654458 2021-03-18
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Women's College Hospital
Phase NA Completed
NCT04626895 2020-11-13
Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers
Medstar Health Research Institute
Phase NA Completed
NCT03101280 2020-10-22
A Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple-Negative Breast Cancer
Hoffmann-La Roche
Phase 1 Completed
NCT02309944 2020-07-27
Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients
Masonic Cancer Center, University of Minnesota
Phase NA Completed
NCT02966327 2020-02-25
Effect of Early Compression and Exercise on Lymphedema Incidence in Patients With Gynecological Cancer
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase NA Completed
NCT03379376 2019-12-30
EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic Surgery
Wake Forest University Health Sciences
Phase NA Completed
NCT02935530 2019-05-14
Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
Huazhong University of Science and Technology
Phase 3 Completed
NCT02786524 2019-03-21
Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy
University of Michigan
Phase NA Completed
NCT02918461 2019-01-04
Emerging From the Haze for Gynecologic Cancer Survivors
Cedars-Sinai Medical Center
Phase NA Completed
NCT00038012 2018-11-01
rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin
M.D. Anderson Cancer Center
Phase NA Completed
NCT01074697 2015-04-24
GAND-emesis
Odense University Hospital
Phase 3 Completed
NCT00523432 2013-09-05
A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies
University of Chicago
Phase 1 Completed
NCT00191646 2011-03-04
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
Eli Lilly and Company
Phase 3 Completed
NCT00377520 2009-11-20
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
Eli Lilly and Company
Phase 2 Completed
NCT00121030 2007-12-24
Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy
Amgen
Phase 2 Completed
NCT00191607 2007-01-26
A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.
Eli Lilly and Company
Phase 3 Completed